CD19 and B-cell chronic lymphocytic leukemia: Fraietta and colleagues [75] describe findings from a 78‐year‐old male with relapsed/refractory chronic lymphocytic leukemia (CLL) treated with chimeric antigen receptor (CAR) T‐cells targeting the CD19 protein.